- Home
- TXO vs LXEO Comparison
TXO vs LXEO Comparison
Compare TXO & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXO
- LXEO
- Stock Information
- Founded
- TXO 2012
- LXEO 2017
- Country
- TXO United States
- LXEO United States
- Employees
- TXO N/A
- LXEO N/A
- Industry
- TXO Oil & Gas Production
- LXEO
- Sector
- TXO Energy
- LXEO
- Exchange
- TXO Nasdaq
- LXEO Nasdaq
- Market Cap
- TXO 701.2M
- LXEO 597.8M
- IPO Year
- TXO 2023
- LXEO 2023
- Fundamental
- Price
- TXO $13.06
- LXEO $9.15
- Analyst Decision
- TXO Strong Buy
- LXEO Strong Buy
- Analyst Count
- TXO 2
- LXEO 8
- Target Price
- TXO $20.50
- LXEO $18.13
- AVG Volume (30 Days)
- TXO 151.4K
- LXEO 1.4M
- Earning Date
- TXO 11-04-2025
- LXEO 11-05-2025
- Dividend Yield
- TXO 18.40%
- LXEO N/A
- EPS Growth
- TXO N/A
- LXEO N/A
- EPS
- TXO 0.36
- LXEO N/A
- Revenue
- TXO $364,412,000.00
- LXEO N/A
- Revenue This Year
- TXO $32.13
- LXEO N/A
- Revenue Next Year
- TXO $11.48
- LXEO N/A
- P/E Ratio
- TXO $36.42
- LXEO N/A
- Revenue Growth
- TXO 27.66
- LXEO N/A
- 52 Week Low
- TXO $12.61
- LXEO $1.45
- 52 Week High
- TXO $20.70
- LXEO $10.38
- Technical
- Relative Strength Index (RSI)
- TXO 41.54
- LXEO 54.84
- Support Level
- TXO $13.15
- LXEO $8.82
- Resistance Level
- TXO $14.09
- LXEO $9.62
- Average True Range (ATR)
- TXO 0.33
- LXEO 0.61
- MACD
- TXO 0.01
- LXEO -0.07
- Stochastic Oscillator
- TXO 19.36
- LXEO 60.33
About TXO TXO Partners L.P.
TXO Partners LP is focused on the acquisition, development, optimization, and exploitation of oil, natural gas, and natural gas liquid reserves in North America.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.